Internship

Software Engineering Intern

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$22.50 - $41.50/hr

No H1B Sponsorship

San Diego, CA, USA

This is a hybrid role requiring on-site participation for team meetings.

Category
Full-Stack Engineering
Software Engineering
Required Skills
Python
Java
C/C++
Requirements
  • Ability to work full-time for 12 weeks during Summer 2025; program dates are May 19, 2025 – August 8, 2025 OR June 16, 2025 – September 5, 2025
  • Computer Science academic studies that will lead to a Bachelor's or Master's Degree (Computer Science, Software Engineering, or Electrical Engineering)
  • Experience with programming languages such as Java, Python, or C++
Responsibilities
  • Developing and enhancing software solutions for medical devices
  • Improving user experience and device performance
Desired Qualifications
  • Excellent critical thinking and problem-solving skills.
  • Strong experiences as demonstrated through projects, research or software engineering internships
  • Great interpersonal relations, team cooperation and communication skills.
  • Exceptional organizational and collaboration skills as demonstrated through leadership positions on teams and/or in student or civic organizations
  • Exceptional communication skills and interest and enthusiasm related to medical technology industry and a career with ResMed

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed's offerings include both medical devices and software subscriptions, which provide ongoing support and services. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of life for patients. The company's goal is to enhance patient care and support healthcare professionals and caregivers across more than 120 countries.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing telehealth adoption boosts demand for ResMed's cloud-connected devices.
  • The sleep apnea devices market is projected to grow at a 7.8% CAGR until 2030.
  • AI integration in healthcare enhances ResMed's diagnostic accuracy and patient outcomes.

What critics are saying

  • Emerging startups in home sleep testing could impact ResMed's market share.
  • Global semiconductor shortages may delay ResMed's product availability.
  • Data privacy concerns could lead to regulatory challenges for ResMed.

What makes Resmed unique

  • ResMed offers cloud-connected solutions for sleep apnea and chronic disease management.
  • The company operates in over 120 countries, providing a global reach.
  • ResMed's focus on reducing hospital visits aligns with healthcare cost reduction needs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

MPO Magazine
Apr 3rd, 2025
Resmed Launches NightOwl Home Sleep Apnea Test

Resmed has launched its NightOwl home sleep apnea test (HSAT) in the U.S.

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).

Healthier Tomorrow
Feb 26th, 2025
ResMed Survey: Despite Sleep Problems, Few Willing to Take Proactive Steps

ResMed today unveiled the findings of its fifth annual Global Sleep Survey.

MarketBeat
Feb 22nd, 2025
Alberta Investment Management Corp Invests $2.38 Million in ResMed Inc. (NYSE:RMD)

Alberta Investment Management Corp invests $2.38 million in ResMed Inc. (NYSE:RMD).

India Med Today
Jan 10th, 2025
ResMed launches AirSense 11 for sleep apnea patients

ResMed launches airsense 11 for sleep apnea patients.